Corazon (Corsee) D. Sanders Ultragenyx Pharmaceutical Inc. (RARE) insider trading activity

Corazon (Corsee) D. Sanders is of Ultragenyx Pharmaceutical Inc.. Currently has a direct ownership of 15,344 shares of RARE, which is worth approximately $635,855. The most recent transaction as insider was on Jun 20, 2025, when has been sold 2,405 shares (Common Stock) at a price of $37.39 per share, resulting in proceeds of $89,922. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 15.3K

27.77% 3M change

27.77% 12M change

Total Value Held $635,855

Corazon (Corsee) D. Sanders Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 20 2025	SELL Open market or private sale	$89,922 $37.39 p/Share	2,405 Reduced 13.55%	15,344 Common Stock
May 15 2025	BUY Grant, award, or other acquisition	-	5,740 Added 24.44%	17,749 Common Stock
Jul 02 2024	SELL Open market or private sale	$23,932 $40.98 p/Share	584 Reduced 4.64%	12,009 Common Stock
Jun 18 2024	BUY Grant, award, or other acquisition	-	5,345 Added 29.8%	12,593 Common Stock
Jun 10 2024	SELL Open market or private sale	$71,390 $41.1 p/Share	1,737 Reduced 19.33%	7,248 Common Stock
Jun 30 2023	SELL Open market or private sale	$27,354 $46.76 p/Share	585 Reduced 6.11%	8,985 Common Stock
Jun 08 2023	SELL Open market or private sale	$76,700 $51.65 p/Share	1,485 Reduced 13.43%	9,570 Common Stock
Jun 07 2023	BUY Grant, award, or other acquisition	-	3,860 Added 25.88%	11,055 Common Stock
Jun 24 2022	BUY Grant, award, or other acquisition	-	3,300 Added 31.44%	7,195 Common Stock
Jun 29 2021	BUY Grant, award, or other acquisition	-	3,895 Added 50.0%	3,895 Common Stock

Also insider at

MTEM

Molecular Templates, Inc. Healthcare

BGNE

BeiGene, Ltd. Healthcare

Director

C(D